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There are ethically sound reasons for research to be conducted on 
diseases affecting populations with lower average income and literacy 
levels. Despite evident global inequalities existing in health measures 
such as mortality, quality of life and disease incidence,[1] only a small 
proportion of medical research focuses on the problems primarily 
affecting the world’s poorest people.[2] It has been argued that applying 
the methods of genomics/biobanking research to these diseases is one 
way to address this imbalance.[3] Increasingly, biobanks have become a 
strategic tool in the field of biotechnology and genomics. In fact, the 
current century has been referred to by Francis Collinsas the ‘genome 
era,’ both in science and in medicine.[4] Authorities in many European 
countries, including the UK biobank[5] and the German National Ethics 
Council[6] have noted the potential of biobanks for the identification 
of causes and the treatment of diseases. Although the definition of 
‘biobank’ is not settled, and is multifaceted, it usually refers to a large 
collection of human biological tissue specimens and related data.[7]
Biobanks have, over the years, become an important means 
of gaining further understanding of the multifactorial nature of 
diseases.[8] Biobanks, as large collections of both tissue samples and 
data, serve as a platform for enabling the sharing of samples and data 
for research, which will ultimately lead to improved health outcomes 
and personalised medicine.[9] Underpinning the significance of data 
sharing in biobank research is a growing call for its recognition as 
a priority for the success of research,[10] particularly in the context of 
biobanking research where tissue samples in the form of DNA, cell 
lines, tissue, plasma, medical information and blood samples have 
become essential tools for research and analysis, to seek and identify 
biomarkers and drug targets for diseases. However, sharing data and 
samples in genomic research via biobank platforms raises a number 
of legal and ethical challenges, regardless of where it is carried out.[11] 
Some of these issues include consent,[12] privacy[13] and the collection, 
storage and release of genomic data.[14] Despite the existence of a 
substantial and developing literature on the ethical and legal issues 
arising from sharing data in biobank research, this literature has as 
yet not adequately addressed the specific legal challenges presented 
by genomics research to the legal systems of lower-middle income 
countries (LMICs) such as Nigeria. De Vries et al.[15] conclude that there 
is a need for guidelines in African countries to be adapted to the 
changing landscape.
The shift to genomic research and data sharing has been facilitated 
by funding from sponsors such as the USA, through the National 
Institutes of Health, and the UK Wellcome Trust, which has encouraged 
collaboration in this regard.[16] However, there has not been as much 
development in the legal frameworks and administration of justice 
in the field of genomic research. In discussing the development of a 
governance framework, at a global level that guarantees equity and 
fairness in biobank collaboration, Chen et al.[17] explain that LMICs 
struggle with data sharing in genomic research for many reasons, 
including culture, religious beliefs and inadequate ethical and legal 
frameworks. In Nigeria, the focus of this paper, the legal framework 
on research is largely developmental, consisting of a patchwork of 
various legislation, which also does not augur well for consistency 
and precision in terms of determining the pervading jurisprudence 
for this area. 
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It is increasingly recognised that effective and appropriate data sharing in biobanking research requires the development of models of good 
data-sharing policy capable of ensuring that the rights and privacy interests of participants are protected. However, the effectiveness and efficacy 
of biobank research depend on data and samples. In the same vein, making such data available to the research community generates tension 
between two important goals: advancing scientific goals, and protecting the individual privacy interests of the tissue source. More critically, data 
sharing requires the development of models that promote an environment in which privacy rights and interests of participants are protected 
throughout the lifecycle of biobank initiatives. Many ethical issues are raised when genomics research is conducted on populations characterised 
by lower average income and literacy levels, such as populations included in lower-middle income countries (LMICs). These issues are further 
exacerbated in Nigeria by cultural and religious inflections. In this paper, to analyse the implications of data sharing within the legal framework 
of an LMIC, an analysis of existing laws in Nigeria was conducted. It was discovered that there were no provisions relating directly to data sharing, 
and its governance framework could only be gleaned from the patchwork of laws on privacy and confidentiality in Nigeria. There is a need for 
ethical guidelines in Nigeria to be adapted to the changing landscape of science, which increasingly involves storage and secondary use of 
samples and data. Current laws are inadequate for the challenges presented by biobanking. 
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The aim of this paper is to analyse and explore data sharing in 
biobank research in Nigeria as a low-income setting, focusing on 
the regulatory instruments that apply directly or tangentially to data 
sharing and biobank research. In analysing this, the article examines 
the legal implications of data sharing for research participants in low-
income settings such as Nigeria. It describes how data sharing tests 
current principles, and discusses ways of resolving these challenges. 
It should be noted, however, that this discussion is not exhaustive, 
as the legal and cultural implications of data sharing in biobanking 
research are broad.
Biobanking research in Nigeria 
Nigeria has recently demonstrated its commitment to, and support for 
genomic research. It is one of only six countries (with Canada, China, 
Japan, the UK and the USA) involved in the International HapMap 
Project. Genomic research continues in Nigeria, and the Nigerian 
government, institutions and scientists are committed to genome 
science and research. Through the intervention of the national 
government, the Nigerian Biotechnology Development Agency 
(NABDA)[18] was established in Abuja,  promoting biotechnology 
across disciplines in health and agriculture. Universities and research 
institutes also receive foreign grants to fund training and research on 
genomic technology and biobanking research, as in the case of the 
Institute of Medical Research and Training (IMRAT) in the Department 
of Virology, University of Ibadan, Nigeria.[19] However, despite Nigeria 
being a pioneering member of the international consortium of 
genomics, the development of a legal regulatory framework in the 
country has been slow,[20] in the sense that local capacity is struggling 
to keep pace with the regulatory and ethical challenges associated 
with genomic and biobank research.
For instance, although some of the nation’s tertiary hospitals 
have tissue collections, the size and specific concentration of each 
repository are unknown. There is a biobank in the country, affiliated 
with the Institute of Human Virology in Nigeria (IHVN), known as 
the H3Africa (Human Heredity and Health in Africa) biobank. The 
H3Africa consortium is an international collaboration of scientists 
engaged in developing genomic research capacity in Africa. The 
biobank currently has 45 358 samples in storage. IHVN also operates 
two repositories in Jos, a capital city in the Middle Belt of Nigeria, 
and Zaria, a major city in Kaduna state in Northern Nigeria. With 
respect to data sharing, informed consent and protection of health 
information, inter alia, the H3Africa biobank in Nigeria does not 
have an independent internal policy guideline, and therefore has to 
rely on those issued by appropriate authorities such as the National 
Health Research Ethics Committee (NHREC) in Nigeria, and in some 
cases the H3Africa consortium. Nonetheless, remarkable progress has 
been recorded in terms of the operation of the biobank.[20] At present, 
the three biorepositories can support long- or short-term storage of 
samples that require –20 or –80oC storage, and the biorepository at the 
National Tuberculosis and Leprosy Training Centre, Kaduna, supports 
the storage of TB isolates and other Mycobacteria.[20] The following 
paragraphs examine the Nigerian legal framework on privacy, data, 
data sharing and human rights, to evaluate the relationship between 
data sharing and the laws in Nigeria. The Nigerian legal framework 
on privacy and data sharing includes statutes, case law, policies and 
guidelines.
Privacy and the Nigerian Constitution 
Generally, data sharing is the practice of making data used for 
scholarly research available to other investigators. In genomic 
research, data sharing is a significant characteristic that allows 
secondary use of data in future, unspecified research. In this regard, 
data sharing poses several problems with respect to trust, privacy and 
uncontrolled secondary use of data, among other issues.[21] Protection 
of individual privacy interests is governed by legal instruments in 
most democracies of the world. Although privacy is not an absolute 
right, derogating or interfering with this right must be justified by law 
as being in the public interest. In Nigeria, the 1999 Constitution of 
the Federal Republic of Nigeria[22] provides for a fundamental human 
right to privacy in the following terms: 
 ‘The privacy of citizens, their homes, correspondence, telephone 
conversations and telegraphic communications is hereby 
guaranteed and protected.’
From the above, although there is no express mention of genomic 
or biobanking research, it is evident that Nigeria recognises and 
protects the right of all its citizens to privacy. It is arguable that 
sharing personal data as correspondence, electronically or via 
telecommunication, without the consent of the individual, can 
infringe an individual’s right to privacy.
National Information Technology Data 
Agency Guidelines
Section 2 of the National Information Technology Data Agency 
(NITDA) guidelines requires that a data controller shall protect 
the privacy of natural persons with respect to the collection and 
processing of personal data, in accordance with their prescription. 
It also requires that data processing shall not take place without the 
consent of the data subject, who in this case is a Nigerian citizen. The 
NITDA is the national authority responsible for planning, developing 
and promoting the use of information technology in Nigeria. It 
is the body saddled with the responsibility of issuing guidelines 
that prescribe the minimum data-protection requirements for the 
collection, storage, processing, management, operation and technical 
controls of information. The guidelines regulate all organisations 
or persons that control, collect, store and process personal data of 
Nigerian residents within and outside Nigeria, for the protection of 
a specific category of data commonly known as personal data, or 
object-identifiable information.[23]
The Freedom of Information Act, 2011[24]
The Freedom of Information Act, 2011 is:
 ‘an Act to make public records and information freely available, 
provide for public access to public records and information, protect 
public records and information to the extent consistent with the 
public interest and the protection of personal privacy, protect 
serving public officers from adverse consequences for disclosing 
certain official information and establish procedures for the 
achievement of those purposes and related purposes thereof.’[25]
The Act deals with information in the custody of public institutions, 
which may include personal and genetic data such as that contained 
in national biobanks. It would appear that the objective of the Act is 
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to provide access to public information that the Official Secrets Act, 
1962[26] hitherto withheld from Nigerians. Again, providing access 
or sharing data creates an inherent conflict between the right to 
privacy on the one hand, and the right to know on the other. The 
reason for this potential conflict is evident: laws of data protection 
and privacy are primarily concerned with the restriction of disclosure 
of information, while freedom of information laws, by design, are 
meant to facilitate general access to information.[27] Even though the 
Nigerian Freedom of Information Act[28] does not specifically cover 
genetic information, it can be safely deduced that genetic information 
in national biobanks may be within the purview of the Official Secrets 
Act.[29] Other than these deductions, there is no judicial interpretation 
on record of this in relation to genetic information. 
Other attempts at legislation
There have been several attempts at legislating data protection in the 
recent past by the Nigerian legislature. Apart from the Nigerian Cyber 
Crime Act, 2015, several Bills have been drafted that address areas 
relating to data sharing in Nigeria; however, to date, most have not 
yet been passed into law. Some of these are: the Computer Security 
and Critical Information Infrastructure Protection Bill, 2005;[30] the 
Cyber Security and Data Protection Agency Bill, 2008;[31] the Nigeria 
Computer Security and Protection Agency Bill, 2009;[32] and the 
Computer Misuse Bill (Amendment) Bill 2010.[33]
Implications of data sharing 
While biobanking research presents both legal and ethical challenges 
regardless of where it is conducted, prospective participants in LMICs 
are more likely to be affected by them, given the inadequate legal 
framework surrounding data sharing.[34,35] Coupled with this is the 
fact that a greater number of the population are poor and have 
limited access to healthcare, education and other resources. This 
means that the carrying out of research in these settings invariably 
presents challenges of a different order than those in higher-income 
countries. In the following section, the paper explores some of the 
challenges presented by genomic research for law relating to privacy 
and obtaining valid consent, both generally and in LMICs.
Informed consent
When individuals provide information about themselves for medical 
treatment, or even medical research, the parameters of informed 
consent are relatively clear, in the sense that there is a presumption 
that such consent was obtained from a competent research subject 
or patient who was given adequate disclosure of information at the 
point of recruitment.[36] In other words, individuals must be told 
what uses their information and samples will be put to, and standard 
notices of privacy practices inform patients that their information 
may be used in lieu of treatment payment, or healthcare operations. 
In biobank research, however, it is usually not as clear-cut. The 
possibility of future use in research is a characteristic of biobank/
genomic research, posing the question of the permissibility of 
later research use. In addition to this, designing consent processes 
for biobanking/genomic research in low-income settings presents 
peculiar challenges, such as language and cultural inflexions.[37] 
For instance, there are difficulties in providing information in a 
comprehensible manner to participants in genomics research, or 
finding synonyms in local dialects to convey information necessary 
to give consent.[38] In genomics, these challenges are presented 
by the need to explain concepts such as ‘genetics’, ‘genomics’ 
and ‘data release’, and the reasons underlying the need to collect 
large quantities of samples and data from healthy populations for 
controls.[39]
Aside from this, one of the peculiarities of genomic research 
is that the data produced have the potential to affect others, in 
the sense that such data can be informative about people other 
than the research participant. Even where personal identifiers are 
removed from genetic datasets, there may arguably be limited risk 
of participant identification. Yet even where this is the case, there 
remains a possibility that unwanted information about populations, 
communities or families can still be revealed. This raises questions 
of privacy protection not only for the research participant, but also 
for communities and population groups. For instance, a genome-
wide association study (GWAS) can reveal that a stigmatising 
condition is more likely to occur in one community than another. 
In that sense, it is possible to generate research results that could 
stigmatise communities, and thus have adverse effects on them 
socially. It is therefore important to consider this when generating 
informed-consent documents or processes for communities such 
as this.
Community engagement through a community advisory board 
(CAB), as envisaged by the Nigerian National Code of Health Research 
Ethics (NCHRE),[40] is intended to be a way to accommodate and 
respect the rights of members of a community engaged in research. 
Under the code, the NHREC is saddled with the responsibility of 
ensuring that communities engaged in research are protected from 
exploitation. The precise definition of exploitation is a subject of 
debate, and the code does not define what it means by exploitation. 
Nonetheless, from its tone and the provisions, it seems to refer to 
exploitation in the sense of taking unfair advantage of community 
members.[41] Therefore, collaborative involvement of a CAB, to provide 
a forum for members of the community to share their views on ethical 
issues that the proposed research raises, is considered a way to reduce 
the potential for exploitation. In relation to data sharing, it would be 
difficult, if not impossible, for members of the community on the 
CAB to effectively share views on data that are yet to be collected, 
analysed and shared. It is doubtful whether these members are 
sufficiently knowledgeable to engage in discussion on implications 
of global data sharing in light of technological advancements in 
the field of genomics and data analysis. Laudable as this provision 
on CABs is, the CAB model has been criticised for being prone to 
limitations such as a lack of power and technical knowledge, and for 
failing to adequately protect the privacy interests of tissue sources in 
population studies, and subsequent data sharing.[42,43]
Privacy and confidentiality within the 
context of African communitarian values
Privacy protects individuals from unwarranted access to the person; 
confidentiality protects information about the person from unwanted 
use or disclosure. Both have been thought to raise special issues 
regarding genomic information. Privacy in the fabric of the African 
ethos and culture raises questions that are different from those in 
Western thought. In African communities, there is a strong awareness 
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of one’s existence and relationship with others in the community, 
a strong sense of ‘social self’. The support of others is seen as more 
important than one’s capacities to achieve one’s own existential 
ends, hence the value placed on corporate existence. According to 
Menkiti,[44] a crucial distinction therefore exists between the African 
view of man and the view in Western thought: in the African view, it 
is the community that defines the person as a person, not necessarily 
an isolated static quality of rationality, will, or memory.
This African social ethic is expressed in many maxims, proverbs, 
extended family relationships and communal living, which all 
emphasise the importance of the values of mutual helpfulness, 
collective responsibility, co-operation, interdependence and 
reciprocal obligations. The extended family setting, for instance, 
reflects an ethic of mutual help, survival and care for each other.[8]
The social, communal or relational character of the African 
prescribes a social ethic rather than one of individualism.[45] 
Individualistic ethics that focus on the welfare and interests of the 
individual are seldom regarded in African moral thought. In African 
cultures, such as in Nigeria, the boundaries of personal privacy 
are narrower. Extended family and communal living tends to blur 
demarcations of personal and spatial privacy within the family 
setting. The extended family setting is essentially a communal one 
in which everyone looks out for the other, including in matters 
relating to health and welfare.[46] Research reveals that when 
conducting genetic screening in Africa, issues of confidentiality are 
not limited solely to the individual participant, but extend to family 
members who are still living, and also, critically, the interests of 
departed souls and those yet unborn.[47]
In an African community, the interests of the community or 
extended family may be more important than the interests of 
the individual. This is because communities may bear risks that 
are not simply aggregates of the risks to individuals, and, in an 
African culture, community participation is a fundamental aspect of 
individual decisions.[48]
Thus the decision to participate in future unspecified research where 
data associated with the community may be shared may be that of 
the community as a whole, in conjunction with the tissue source. 
Despite the fact that the margin of privacy is narrower in African 
communities, however, the concept of privacy within communities 
is not discounted. Privacy, as the concept of being left alone to 
make choices best suited to the individual, remains the norm in 
these communities. The application of privacy to the individual, as 
opposed to a corporate norm, is the point of digression from Western 
thought in African communities.[38] According to de Vries et al.,[39] data 
sharing and research in communities with a communal ethos present 
important ethical challenges that have been shown to differ from 
those with an individualistic Western ethos in significant ways.
Conclusion and recommendations
There is a need for more research on the legal and ethical implications 
of data sharing for Nigerians and other citizens of LMICs. Data on 
African communities and localities where re-identification is possible 
should be secured. Genomic data need to be secured with up-to-
date security software back-up, and this should be made a legal 
requirement. Currently, most laws relating to data sharing in Nigeria 
fail to adequately describe biobanking research or genomics.
The perspectives of Nigerians and other citizens of LMICs on data 
sharing policies as they exist are sparsely represented in the literature, 
and therefore more social science research should examine this aspect.
Community involvement should be as important as individual 
consent in these settings, yet it should not override or substitute for 
an individual’s choice as to whether or not to participate in future, 
unspecified research.[49]
Identifying and recognising the ethical challenges that arise in 
diverse, though interconnected, ways in different research settings 
is a step in the right direction. However, this requires more legal and 
social science-based research, to establish a proper understanding 
of the legal jurisprudence and perspectives of relevant low-income 
settings regarding what constitutes legally acceptable and ethical 
data sharing.
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